Literature DB >> 18491687

Development and validation of a scale to measure socioeconomic well-being in persons with cancer.

Barbara Anderson Head1, Anna C Faul.   

Abstract

Socioeconomic factors substantially impact the quality of life (QOL) of persons diagnosed with cancer, yet socioeconomic well-being seldom is included as an essential domain when overall QOL is measured. This study details the development and psychometric analysis of a scale for measuring socioeconomic well-being in persons diagnosed with cancer. Coleman's theory of social class was used to define and develop the construct. The resulting scale consisting of two subscales--Material and Social Capital-demonstrated acceptable reliability, content and construct validity at both scale and item levels, and acceptable discriminant, convergent, and incremental validity.

Entities:  

Mesh:

Year:  2008        PMID: 18491687

Source DB:  PubMed          Journal:  J Support Oncol        ISSN: 1544-6794


  11 in total

Review 1.  Financial Hardship--an Unwanted Consequence of Cancer Treatment.

Authors:  Julie McNulty; Nandita Khera
Journal:  Curr Hematol Malig Rep       Date:  2015-09       Impact factor: 3.952

2.  Psychometric properties of self-reported financial toxicity measures in cancer survivors: a systematic review.

Authors:  Zheng Zhu; Weijie Xing; Huan Wen; Yanling Sun; Winnie K W So; Lucylynn Lizarondo; Jian Peng; Yan Hu
Journal:  BMJ Open       Date:  2022-06-24       Impact factor: 3.006

3.  Interventions to address cancer-related financial toxicity: Recommendations from the field.

Authors:  Jean Edward; Victoria M Petermann; Jan M Eberth; Whitney E Zahnd; Robin C Vanderpool; Natoshia Askelson; Catherine L Rohweder; Sarah Koopman Gonzalez; Lindsay R Stradtman; Linda K Ko; Paige E Farris
Journal:  J Rural Health       Date:  2021-12-03       Impact factor: 5.667

4.  Patient Attitudes Regarding the Cost of Illness in Cancer Care.

Authors:  Barry R Meisenberg; Ashley Varner; Erin Ellis; Stephen Ebner; John Moxley; Erika Siegrist; David Weng
Journal:  Oncologist       Date:  2015-09-01

5.  Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers.

Authors:  John M Salsman; Suzanne C Danhauer; Justin B Moore; Edward H Ip; Laurie E McLouth; Chandylen L Nightingale; Christabel K Cheung; Kristin M Bingen; Reginald D Tucker-Seeley; Denisha Little-Greene; Dianna S Howard; Bryce B Reeve
Journal:  Cancer       Date:  2021-04-13       Impact factor: 6.921

6.  Financial impact of allogeneic hematopoietic cell transplantation on patients and families over 2 years: results from a multicenter pilot study.

Authors:  E M Denzen; V Thao; T Hahn; S J Lee; P L McCarthy; J D Rizzo; M Ammi; R Drexler; S Flesch; H James; N Omondi; E Murphy; K Pederson; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2016-04-18       Impact factor: 5.483

7.  Methods for measuring financial toxicity after cancer diagnosis and treatment: a systematic review and its implications.

Authors:  J Witte; K Mehlis; B Surmann; R Lingnau; O Damm; W Greiner; E C Winkler
Journal:  Ann Oncol       Date:  2019-07-01       Impact factor: 32.976

8.  Psychometric properties of self-reported financial toxicity measures in cancer survivors: a systematic review protocol using COSMIN methodology.

Authors:  Zheng Zhu; Weijie Xing; Lucylynn Lizarondo; Jian Peng; Yan Hu; Winnie Kw So
Journal:  BMJ Open       Date:  2020-05-17       Impact factor: 2.692

Review 9.  Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.

Authors:  Meredith J Doherty; Bridgette Thom; Francesca Gany
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-02       Impact factor: 4.090

10.  A mixed method exploration of survivorship among Chinese American and non-Hispanic White breast cancer survivors: the role of socioeconomic well-being.

Authors:  Judy Huei-yu Wang; Inez F Adams; Reginald Tucker-Seeley; Scarlett Lin Gomez; Laura Allen; Ellen Huang; Yiru Wang; Rena J Pasick
Journal:  Qual Life Res       Date:  2013-04-17       Impact factor: 3.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.